Survival Noninferior With Heart Donated After Circulatory Death
FRIDAY, June 9, 2023 (HealthDay News) — Risk-adjusted survival at six months after transplantation is noninferior for patients receiving a heart after the circulatory death of a donor or after brain death of a donor, according to a study published in…
Learn MoreRisk for Stroke Increased in Association With Insomnia Symptoms
FRIDAY, June 9, 2023 (HealthDay News) — Insomnia symptoms are associated with an increased risk for stroke, with a dose-response relationship, according to a study published online June 7 in Neurology.Wendemi Sawadogo, M.D., M.P.H., from Virginia Com…
Learn MoreMany Cancer Centers Experiencing Shortage of Carboplatin, Cisplatin
THURSDAY, June 8, 2023 (HealthDay News) — Ninety-three and 70 percent of cancer centers are currently experiencing a shortage of carboplatin and cisplatin, respectively, according to a report published June 7 by the National Comprehensive Cancer Netw…
Learn MoreAlmost All Blood Donors Had SARS-CoV-2 Antibodies by Third Quarter of 2022
THURSDAY, June 8, 2023 (HealthDay News) — Almost all blood donors had severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies from previous infection or vaccination by the third quarter of 2022, with the prevalence of hybrid immunity …
Learn MoreCOVID-19-Associated Smell, Taste Disturbance Is Declining
THURSDAY, June 8, 2023 (HealthDay News) — During recent omicron waves, there was a decrease in the rate of COVID-19-associated smell or taste disturbance, according to a study published online May 26 in Otolaryngology-Head and Neck Surgery.Evan R. Re…
Learn MoreMammographic AI Algorithms Improve Breast Cancer Prediction
THURSDAY, June 8, 2023 (HealthDay News) — Mammography artificial intelligence (AI) algorithms perform better than the Breast Cancer Surveillance Consortium (BCSC) risk model for predicting breast cancer risk, according to a study published online Jun…
Learn MoreASCO: Cilta-Cel Beneficial for Lenalidomide-Refractory Multiple Myeloma
THURSDAY, June 8, 2023 (HealthDay News) — For patients with lenalidomide-refractory multiple myeloma, a single cilta-cel infusion results in lower risk of disease progression or death compared with standard care, according to a study published online…
Learn MoreASCO: Drug Combo Ups Progression-Free Survival for Metastatic Prostate Cancer
THURSDAY, June 8, 2023 (HealthDay News) — For patients with metastatic castration-resistant prostate cancer (mCRPC), talazoparib plus enzalutamide results in improvement in radiographic progression-free survival (rPFS), according to a study published…
Learn MoreGuidelines Developed for ED Management of New Dizziness, Vertigo
THURSDAY, June 8, 2023 (HealthDay News) — In a consensus statement published in the May issue of Academic Emergency Medicine, guidelines are presented for the emergency department management of patients with new dizziness or vertigo without an obviou…
Learn MoreProportion of Outpatient Pediatric Visits With Anxiety Up Over Time
THURSDAY, June 8, 2023 (HealthDay News) — For pediatric patients, the proportion of outpatient visits with a diagnosis of anxiety increased over time from 2006 to 2018, but the proportion with any therapy decreased, according to a study published onl…
Learn More